Hall M, Monka C, Krupp P, OSullivan D. Safety of oral terbinafine: results of a postmarketing surveillance study in 25,884 patients. Arch Dermatol 1997;133:1213-1219
OSullivan DP, Needham CA, Bangs A, Atkin K, Kendall FD. Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study. Br J Clin Pharmacol 1996;42:559-565
Kantarcıoğlu B, Türköz HK, Yılmaz G, Tanrıkulu FP, Atagündüz IK, Adıgüzel C, Tuğlular TF. Aplastic anemia associated with oral terbinafine: a case report and review of the literature. Turk J Hematol 2014;31:411-416
Yavaşoğlu İ, Arslan E. Neutropenia due to terbinafine. Osmangazi Tıp Dergisi 2008;30:59-62.